mAbxience |

A 3D-printed human skin dressing, a migraine predictor and a smart insulin pen: the three startups selected for support by Insud Pharma

02/18/2019

BioDan, a 3D dressing derived from human skin which can be bioprinted and frozen, Brainguard, a wearable system that predicts migraines, and Insulclock, a system which monitors and controls the treatment of diabetes patients are the three startups selected in the second round of the ChemoStart accelerator programme, which seeks to support innovative, disruptive solutions […]

Twelve startups present disruptive healthcare solutions at Insud Pharma’s Pitch Day

01/30/2019

• The ChemoStart Programme is an initiative by Insud Pharma, spearheaded by Leandro Sigman, to support innovative healthcare startups   • In the second edition of the programme, 12 finalists have been shortlisted to present to a panel of experts at the Pitch Day on Thursday 31 January Madrid, 30 January 2019.- Insud Pharma’s startup […]

Publication of the final data from the clinical trial for mAbxience bevacizumab in metastatic colorectal cancer published in The Lancet Gastroenterology & Hepatology

09/27/2018

The prestigious scientific journal The Lancet Gastroenterology and Hepatology journal has published the results of the comparative study of pharmacokinetics, efficacy, safety and immunogenicity of bevacizumab biosimilar BEVZ92 in combination with FOLFOX or FOLFIRI, as the first-line treatment for metastatic colorectal cancer versus the original reference product.  The trial included 15 sites from 5 countries, […]

Insud Pharma secures “very good” rating in the Profarma Programme

09/24/2018

mAbxience and the entire Insud Pharma group have once again been rated “very good” in the 2017-2020 edition of the Spanish government’s Profarma Programme, thanks to our contribution to modernising the sector, our commitment to R&D and our clear focus on activities that add value. The Programme is run by the Spanish Ministry of Economy, […]

mAbxience, sponsor of BIOSPAIN 2018

09/13/2018

BIOSPAIN, the largest biotech event organized by a national bioindustry association in Europe (ASEBIO), and one of the largest in the world by the number of one-to-one meetings (+3.000) and companies participating (+800), will celebrate a new edition in Seville from 25th to 27th September 2018. mAbxience, bronze sponsor of the event, will take part […]

The Autonomous University of Madrid and Insud Pharma 
join forces for biomedical innovation

07/16/2018

The Autonomous University of Madrid (UAM) and the multinational pharmaceutical company Insud Pharma are launching the UAM-Insud Pharma Programme of Innovation Challenges with a Strong Social Impact for biomedical innovation with an open innovation approach that enables the transfer of knowledge through science excellence to overcome some of the specific challenges of our society. This […]